Militia Capital Partners LP Boosts Stake in National HealthCare Corporation $NHC

Posted by Geri Gentry on Jun 17th, 2026

Militia Capital Partners LP raised its position in National HealthCare Corporation (NYSEAMERICAN:NHC – Free Report) by 103.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,000 shares of the company’s stock after buying an additional 5,600 shares during the period. Militia Capital Partners LP owned 0.07% of National HealthCare worth $1,508,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Mariner LLC increased its stake in National HealthCare by 0.9% in the 4th quarter. Mariner LLC now owns 6,839 shares of the company’s stock valued at $938,000 after buying an additional 59 shares during the last quarter. Barclays PLC increased its stake in National HealthCare by 10.1% in the 4th quarter. Barclays PLC now owns 19,805 shares of the company’s stock valued at $2,715,000 after buying an additional 1,820 shares during the last quarter. Bridge City Capital LLC purchased a new stake in National HealthCare in the 4th quarter valued at about $2,237,000. Aigen Investment Management LP increased its stake in shares of National HealthCare by 97.8% during the 4th quarter. Aigen Investment Management LP now owns 3,687 shares of the company’s stock worth $505,000 after purchasing an additional 1,823 shares during the last quarter. Finally, Kestra Advisory Services LLC purchased a new stake in shares of National HealthCare during the 4th quarter worth approximately $42,000. Hedge funds and other institutional investors own 56.44% of the company’s stock.

National HealthCare Price Performance

Shares of NYSEAMERICAN:NHC opened at $191.97 on Wednesday. The firm has a fifty day moving average price of $181.83 and a two-hundred day moving average price of $160.78. National HealthCare Corporation has a one year low of $93.54 and a one year high of $205.06. The company has a market cap of $3.00 billion, a price-to-earnings ratio of 24.39 and a beta of 0.64.

National HealthCare (NYSEAMERICAN:NHC – Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The company reported $1.91 EPS for the quarter. National HealthCare had a net margin of 8.10% and a return on equity of 9.98%. The firm had revenue of $381.82 million during the quarter.

National HealthCare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be issued a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend is Tuesday, June 30th. This is a positive change from National HealthCare’s previous quarterly dividend of $0.64. National HealthCare’s payout ratio is 59.12%.

Insider Buying and Selling

In other news, Director Lisa Piercey purchased 949 shares of the business’s stock in a transaction on Monday, June 1st. The stock was purchased at an average cost of $184.26 per share, with a total value of $174,862.74. Following the acquisition, the director directly owned 949 shares in the company, valued at approximately $174,862.74. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 13.92% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on NHC. The Goldman Sachs Group upgraded shares of National HealthCare to a “strong-buy” rating in a research note on Monday, May 18th. Royal Bank Of Canada upgraded shares of National HealthCare to a “hold” rating in a research note on Monday, May 18th. BMO Capital Markets upgraded shares of National HealthCare to a “hold” rating in a research note on Monday, May 18th. Finally, Robert W. Baird upgraded shares of National HealthCare to a “strong-buy” rating in a research note on Monday, May 18th. Two analysts have rated the stock with a Strong Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, National HealthCare currently has a consensus rating of “Buy”.

Get Our Latest Analysis on National HealthCare

National HealthCare Profile

(Free Report)

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.